- Five-day intermittent theta-burst stimulation produced rapid, significant reductions in suicidal ideation, behaviour and suicide risk with large effect sizes (p < 0.001).
- End-of-treatment response and remission rates for suicidal ideation were 97.1% and 73.5% respectively, indicating robust acute clinical benefit.
- Clinical improvements were largely sustained at one month with maintained response and remission, and comparable efficacy in unipolar and bipolar patients.
Arch Suicide Res. 2026 Oct 7:1-19. doi: 10.1080/13811118.2026.2743267. Online ahead of print.
ABSTRACT
BACKGROUND: Suicidal ideation and behavior are major clinical challenges depression, and rapid-acting interventions remain limited. Intermittent theta-burst stimulation (iTBS) has emerged as a promising neuromodulatory technique with potential anti-suicidal and antidepressant effects.
OBJECTIVE: To evaluate the efficacy of iTBS in reducing suicidal ideation and behavior in patients with unipolar and bipolar depression.
METHODS: Thirty-four patients with depression (17 unipolar, 17 bipolar) completed a 5-day iTBS treatment protocol. Suicidal ideation severity and intensity, suicidal behavior and suicidal risk were assessed at baseline and daily during treatment and after one month using the C-SSRS.
RESULTS: iTBS produced significant reductions in suicidal ideation severity and intensity, suicidal behavior, and suicidal risk in both groups (p < 0.001). Large effect sizes were observed for all outcomes. At the end of treatment, the response and remission rates for suicidal ideation were 97.1% and 73.5%, respectively. No significant differences were observed between unipolar and bipolar patients in overall treatment efficacy, although bipolar patients showed slightly greater improvement in suicidal ideation intensity. At the one-month follow-up, response rates for suicidal ideation were 80% in the unipolar group and 75% in the bipolar group, with remission maintained in 60% and 62.5% of patients, respectively, and an absence of suicidal behavior reported by 100% and 93.8% of each group.
CONCLUSION: iTBS is a rapid, effective intervention for reducing suicidality in both unipolar and bipolar depression. The one-month follow-up data indicates that the clinical improvements observed at the end of the five-day treatment course were largely sustained in both groups.
PMID:42842759 | DOI:10.1080/13811118.2026.2743267
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
